Mitochondrial Dysfunction in the Pathogenesis of Ullrich Congenital Muscular Dystrophy and Prospective Therapy with Cyclosporins.
From: Department of Biomedical Sciences and Institute of Neuroscience, Consiglio Nazionale delle Ricerche, University of Padua, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.
Proceedings of the National Academy of Sciences of the United States of America
- Publish Date: Jan 2007
- ISSN: 0027-8424
- Volume: 104
- Issue: 3
- Pages: 991-6
- Medium: Print
- Language: English
- Citation (JAMA): Angelin Alessia, Tiepolo Tania, Sabatelli Patrizia, et al. Mitochondrial Dysfunction in the Pathogenesis of Ullrich Congenital Muscular Dystrophy and Prospective Therapy with Cyclosporins.. Proc. Natl. Acad. Sci. U.S.A. Jan 2007;104:991-6
Abstract
Ullrich congenital muscular dystrophy is a severe genetically and clinically heterogeneous muscle disorder linked to collagen VI deficiency. The pathogenesis of the disease is unknown. To assess the potential role of mitochondrial dysfunction in the onset of muscle fiber death in this form of dystrophy, we studied biopsies and myoblast cultures obtained from patients with different genetic defects of collagen VI and variable clinical presentations of the disease. We identified a latent mitochondrial dysfunction in myoblasts from patients with Ullrich congenital muscular dystrophy that matched an increased occurrence of spontaneous apoptosis. Unlike those in myoblasts from healthy donors, mitochondria in cells from patients depolarized upon addition of oligomycin and displayed ultrastructural alterations that were worsened by treatment with oligomycin. The increased apoptosis, the ultrastructural defects, and the anomalous response to oligomycin could be normalized by Ca(2+) chelators, by plating cells on collagen VI, and by treatment with cyclosporin A or with the specific cyclophilin inhibitor methylAla(3)ethylVal(4)-cyclosporin, which does not affect calcineurin activity. Here we demonstrate that mitochondrial dysfunction plays an important role in muscle cell wasting in Ullrich congenital muscular dystrophy. This study represents an essential step toward a pharmacological therapy of Ullrich congenital muscular dystrophy with cyclosporin A and methylAla(3)ethylVal(4) cyclosporin.
Mesh Headings (Keywords): Adult, Apoptosis, Cells, Cultured, Child, Child, Preschool, Collagen Type VI, Cyclosporins, Humans, Microscopy, Electron, Mitochondria, Muscle, Muscular Dystrophies, Mutation
Check for Full Text / PubMed Unique Identifier (PMID): 17215366
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.